ArticleBMC cancer2025
Risk-reducing salpingectomy: considerations from an OBGYN perspective.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07532434 (A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
Who cites it
1 citing paper in PubMed.
- Complications Following Bilateral Salpingectomy by Indication: Population-Based Cohort Study.BJOG : an international journal of obstetrics and gynaecology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith recent evidence that opportunistic salpingectomy is effective in preventing high grade serous carcinoma, it is imperative to consider the optimal use of this procedure. In this research, we investigated the opinions of obstetrician-gynecologists (OBGYNS) about the acceptability of using salpingectomy as a stand-alone surgery for people at higher-than-average lifetime risk (but without a pathogenic variant that increases risk for ovarian cancer) known as ‘risk-reducing salpingectomy’(RRS).
methodsWe conducted semi-structured interviews with purposefully sampled practicing OBGYNs in the province of British Columbia, Canada. We used qualitative interpretive description with inductive thematic analysis for data analysis. Our work was informed by the theoretical framework of acceptability.
resultsThe nineteen participants included physicians from both general obstetrics and gynecology practices, as well as subspecialties. OBGYNs generally found RRS to be acceptable, though this acceptability was conditional on clinical, patient, and system-level factors. Five major themes suggest that: (1) There are risks and benefits of RRS, that if balanced might support acceptability; (2) It is important to define and identify the correct patient for RRS; (3) OBGYNs value patient autonomy in the decision to undergo RRS; (4) Reproductive justice and equity are intertwined and influenced by the history of forced and coerced sterilization; and (5) Formal guidance and the right environment are enablers of RRS.
conclusionsThis work provides initial evidence that, from the OBGYN perspective, RRS is acceptable in the right patient population, with considerations from those practicing on the front lines of ovarian cancer prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.